## Overview
A runny nose — medically termed **rhinorrhea** (ICD-10: R09.81) — refers to excess nasal discharge that drips from the nostrils or drains posteriorly into the throat (post-nasal drip). The discharge may be thin and watery, thick and mucoid, or purulent (yellow-green), depending on the underlying cause.
Rhinorrhea is one of the most common symptoms encountered in primary care. Upper respiratory infections alone account for roughly 500 million episodes per year in the United States, with rhinorrhea as a near-universal feature [1]. Allergic rhinitis affects an estimated 10–30% of adults worldwide and up to 40% of children, making it the leading chronic cause of a runny nose [6]. Because the symptom is so pervasive, it is among the most frequently searched health terms online, with people seeking reassurance about whether their runny nose is "just a cold" or something more serious.
While rhinorrhea is usually benign and self-limiting, it can occasionally signal conditions that require prompt evaluation — including cerebrospinal fluid (CSF) leak, foreign body aspiration in children, or invasive infections. Understanding the mechanism, duration, and character of nasal discharge helps guide appropriate self-care, over-the-counter (OTC) treatment, or timely referral.
## Common Causes
The nasal mucosa produces approximately one liter of mucus daily under normal conditions. Rhinorrhea occurs when production increases, clearance decreases, or both. Below are the most common causes, ranked roughly by frequency.
### 1. Viral Upper Respiratory Infection (Common Cold)
Rhinoviruses (responsible for ~50% of colds), coronaviruses, and other respiratory viruses invade nasal epithelial cells, triggering an inflammatory cascade that increases vascular permeability and stimulates goblet-cell secretion [1]. The characteristic progression — watery discharge for 1–2 days, thickening to mucoid over 3–5 days, resolution within 7–10 days — reflects the immune response rather than bacterial superinfection.
### 2. Allergic Rhinitis
Inhalant allergens (pollen, dust mites, pet dander, mold) cross-link IgE on mast cells in the nasal mucosa, causing degranulation and release of histamine, leukotrienes, and prostaglandins. This produces the classic triad of rhinorrhea, sneezing, and nasal congestion [6]. Allergic rhinorrhea is typically bilateral, watery, and accompanied by eye itching.
### 3. Non-Allergic Rhinitis (Vasomotor Rhinitis)
A heterogeneous group of conditions characterized by nasal hyper-reactivity to non-allergic triggers — temperature changes, strong odors, humidity, spicy foods (gustatory rhinitis), and hormonal fluctuations [3]. The discharge is generally clear and watery. Skin-prick testing and specific IgE are negative.
### 4. Sinusitis (Rhinosinusitis)
When sinus ostia become blocked — often following a viral URI — retained secretions may become secondarily infected. Acute bacterial rhinosinusitis (ABRS) is suggested by symptoms lasting >10 days without improvement, "double worsening" (initial improvement followed by deterioration), or high fever with purulent discharge lasting ≥3 days. Discharge is characteristically thick, discolored, and often unilateral.
### 5. Medication-Induced (Drug-Induced Rhinitis)
Overuse of topical decongestant sprays (oxymetazoline, phenylephrine) for more than 3–5 consecutive days can produce rebound congestion and rhinorrhea known as **rhinitis medicamentosa**. Other medications implicated include ACE inhibitors, beta-blockers, oral contraceptives, NSAIDs, and some antihypertensives [3].
### 6. Environmental Irritants
Tobacco smoke, air pollution, occupational chemicals, and dry indoor air can trigger a non-allergic inflammatory response in the nasal mucosa, increasing mucus output.
### 7. Structural Causes
Deviated nasal septum, nasal polyps, and adenoid hypertrophy (especially in children) may impair normal mucociliary clearance, resulting in chronic or recurrent rhinorrhea.
### 8. Cerebrospinal Fluid (CSF) Leak (Rare but Serious)
Unilateral, clear, watery discharge that worsens with leaning forward or straining may indicate a CSF leak, typically following head trauma or sinus/skull base surgery. This requires urgent evaluation.
## RED FLAGS
Seek **immediate medical attention** (ER or call emergency services) if a runny nose is accompanied by any of the following:
- **Clear, watery, unilateral discharge after head trauma** — may indicate CSF leak; risk of meningitis
- **High fever (≥ 39.4 °C / 103 °F) with facial swelling, severe headache, or vision changes** — possible orbital or intracranial complication of sinusitis
- **Bloody discharge (epistaxis) that does not stop with 20 minutes of direct pressure**, especially if on anticoagulant therapy
- **Difficulty breathing, wheezing, or throat swelling** accompanying acute-onset rhinorrhea — possible anaphylaxis
- **Stiff neck, confusion, or photophobia** with nasal discharge and fever — consider meningitis
- **Suspected foreign body in a child** — unilateral, foul-smelling, purulent or bloody discharge
- **Rapidly progressive facial pain and dark or necrotic tissue** visible in the nose, particularly in immunocompromised or diabetic patients — concern for invasive fungal sinusitis
## Self-Care at Home
The following non-pharmacological measures have evidence supporting their use in managing rhinorrhea.
### Nasal Saline Irrigation
Isotonic or hypertonic saline irrigation (using a neti pot, squeeze bottle, or commercial device) mechanically clears mucus, allergens, and inflammatory mediators from the nasal cavity. A Cochrane review found that saline irrigation may provide symptomatic relief in both acute URIs and chronic rhinosinusitis [5]. Use distilled, sterile, or previously boiled and cooled water to avoid rare but serious infections (e.g., *Naegleria fowleri*).
### Hydration
Adequate fluid intake (water, broth, warm teas) helps keep mucus thin and easier to clear. While direct evidence for increased fluids curing colds is limited, dehydration thickens secretions and worsens symptoms.
### Steam Inhalation
Inhaling warm, humidified air (from a bowl of hot water or a hot shower) may temporarily relieve nasal congestion and promote mucus drainage. Evidence is modest, and care must be taken to avoid burns, especially in children.
### Elevate the Head During Sleep
Using an extra pillow or raising the head of the bed by 15–20° can reduce post-nasal drip and nighttime congestion by promoting gravitational sinus drainage.
### Allergen Avoidance
For allergic rhinitis, reducing exposure to identified triggers is a first-line strategy [6]. Key measures include using allergen-proof pillow and mattress covers, keeping windows closed during high-pollen seasons, showering after outdoor activity, and using HEPA air purifiers.
### Warm Compresses
Applying a warm, damp cloth over the sinuses may relieve facial pressure and promote drainage in sinusitis-related rhinorrhea.
## OTC Medications That Help
The table below summarizes commonly used over-the-counter options by drug class.
| Class | Example(s) | Typical Adult Dose | Mechanism | Key Notes / Contraindications |
|---|---|---|---|---|
| **Oral antihistamines (2nd-gen)** | Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra) | Cetirizine 10 mg once daily; loratadine 10 mg once daily; fexofenadine 180 mg once daily | Block H1 receptors, reducing histamine-mediated secretion and itch | Preferred for allergic rhinitis; less sedation than 1st-gen. Cetirizine may still cause mild drowsiness. Generally ineffective for non-allergic rhinorrhea [7]. |
| **Oral antihistamines (1st-gen)** | Diphenhydramine (Benadryl), chlorpheniramine | Diphenhydramine 25–50 mg every 6–8 h; chlorpheniramine 4 mg every 4–6 h | H1 blockade plus anticholinergic drying effect | May reduce rhinorrhea in colds due to anticholinergic properties [8]. Causes significant drowsiness. Avoid in elderly (Beers list), BPH, narrow-angle glaucoma. |
| **Intranasal corticosteroids** | Fluticasone propionate (Flonase), triamcinolone (Nasacort), budesonide (Rhinocort) | 1–2 sprays per nostril once daily | Reduce mucosal inflammation, goblet-cell secretion, and vascular permeability | Gold standard for allergic rhinitis [2]. Takes 1–2 weeks for full effect. Now available OTC. Minimal systemic absorption. |
| **Topical decongestants** | Oxymetazoline (Afrin), phenylephrine nasal spray | 2–3 sprays per nostril every 12 h (oxymetazoline) | Alpha-adrenergic agonist; vasoconstriction reduces mucosal edema | Rapid relief of congestion. **Do not use >3 consecutive days** to avoid rhinitis medicamentosa [4]. Avoid in uncontrolled hypertension. |
| **Oral decongestants** | Pseudoephedrine (Sudafed), phenylephrine (oral) | Pseudoephedrine 60 mg every 4–6 h or 120 mg extended-release every 12 h | Systemic alpha-adrenergic vasoconstriction | Pseudoephedrine is more effective than oral phenylephrine [4]. Behind the pharmacy counter (US). Avoid in uncontrolled hypertension, severe coronary artery disease, MAO inhibitor use. |
| **Intranasal anticholinergic (OTC in some countries)** | Ipratropium bromide 0.03% (Atrovent Nasal) — Rx in US, OTC in some markets | 2 sprays per nostril 2–3 times daily | Blocks muscarinic receptors, reducing glandular secretion | Particularly effective for watery rhinorrhea (vasomotor/gustatory rhinitis and common cold). Does not relieve congestion. |
| **Saline sprays / rinses** | NeilMed, Ocean Spray, Navage | As needed; irrigation 1–3 times daily | Mechanical clearance of mucus and irritants | No contraindications. Safe for all populations including pregnancy [5]. |
> **Note:** A 2015 Cochrane review concluded that antihistamines have a modest beneficial effect on rhinorrhea severity in the first 1–2 days of a common cold, but the clinical significance is small and side effects (sedation) may offset benefits [8].
## Prescription Options
Prescription medications are generally indicated when OTC measures fail, symptoms are chronic or severe, or specific diagnoses require targeted therapy.
| Class | Example(s) | Typical Adult Dose | When Used / Notes |
|---|---|---|---|
| **Intranasal anticholinergic** | Ipratropium bromide 0.03% (Atrovent Nasal) | 2 sprays per nostril 2–3 times daily | First-line Rx for vasomotor rhinitis and cold-related watery rhinorrhea [3]. May cause nasal dryness, epistaxis. |
| **Intranasal antihistamines** | Azelastine (Astelin/Astepro), olopatadine (Patanase) | Azelastine 1–2 sprays per nostril twice daily | Effective for both allergic and non-allergic rhinitis [2]. May cause bitter taste, drowsiness. Available OTC (Astepro) in the US since 2022. |
| **Combination nasal spray** | Azelastine/fluticasone (Dymista) | 1 spray per nostril twice daily | Superior to either component alone for moderate-to-severe allergic rhinitis [6]. Prescription only. |
| **Leukotriene receptor antagonist** | Montelukast (Singulair) | 10 mg once daily at bedtime | Second- or third-line for allergic rhinitis, especially with comorbid asthma. FDA boxed warning (2020) for neuropsychiatric events; discuss risks vs. benefits. |
| **Oral corticosteroids** | Prednisone | Short taper, e.g., 30–40 mg daily × 5–7 days | Reserved for severe nasal polyposis or refractory rhinosinusitis; prescribed by ENT or allergist. Not for routine rhinorrhea. |
| **Antibiotics** | Amoxicillin-clavulanate, doxycycline | Amoxicillin-clavulanate 875/125 mg twice daily × 5–10 days | Only for confirmed or strongly suspected acute bacterial rhinosinusitis (symptoms >10 days without improvement or "double worsening"). Most rhinorrhea is viral — antibiotics do not help and contribute to resistance [2]. |
| **Immunotherapy** | Subcutaneous (SCIT) or sublingual (SLIT) allergen immunotherapy | Individualized by allergist | For allergic rhinitis inadequately controlled by medications or when long-term disease modification is desired. Requires 3–5 year course. Prescribing and initiation by allergist [6]. |
## Lab Tests Typically Ordered
Most cases of acute rhinorrhea require no laboratory evaluation. When symptoms are persistent, recurrent, or atypical, the following tests may be considered:
| Test | Rationale | When Ordered |
|---|---|---|
| **Nasal cytology / smear** | Eosinophils suggest allergic rhinitis; neutrophils suggest infection | Chronic rhinorrhea of unclear etiology |
| **Skin-prick testing (SPT)** or **serum specific IgE** (e.g., ImmunoCAP) | Identifies specific allergen sensitization | Suspected allergic rhinitis when triggers are unclear [7] |
| **Complete blood count (CBC) with differential** | Eosinophilia may support allergic etiology; leukocytosis suggests infection | Chronic symptoms or suspected systemic allergic disease |
| **Total serum IgE** | Elevated levels support atopic disease but are non-specific | Adjunct to specific IgE testing |
| **CT sinuses (imaging, not lab)** | Evaluates sinusitis complications, polyps, structural abnormalities | Chronic rhinosinusitis (≥12 weeks), suspected complications, pre-surgical planning |
| **Beta-2 transferrin** | Highly specific marker for CSF; confirms CSF rhinorrhea | Clear, unilateral rhinorrhea after trauma or surgery — suspected CSF leak |
| **Nasal endoscopy** | Direct visualization of nasal cavity, turbinates, sinus ostia, polyps | Persistent unilateral symptoms, suspected polyps, foreign body, tumor |
## Special Populations
### Children
- Children average **6–8 colds per year**, compared to 2–3 in adults, making rhinorrhea a very frequent pediatric complaint [1].
- **Saline drops and gentle nasal suctioning** (bulb syringe) are first-line for infants and toddlers.
- **OTC cough and cold medications are NOT recommended for children under 6 years** (FDA advisory, 2008). The American Academy of Pediatrics advises against their use in this age group due to lack of efficacy and risk of serious adverse effects.
- **Second-generation antihistamines** — cetirizine is approved for children ≥6 months for allergic rhinitis; loratadine and fexofenadine are approved for ≥2 years. Always use weight-appropriate, age-specific formulations. Consult a pediatrician for dosing.
- **Intranasal corticosteroids** — fluticasone furoate (Flonase Sensimist) is approved for ≥2 years; mometasone (Nasonex) for ≥2 years for allergic rhinitis. Monitor growth velocity with prolonged use.
- **Unilateral foul-smelling discharge** in a child should always prompt evaluation for a nasal **foreign body**.
### Pregnancy
- **Pregnancy rhinitis** affects approximately 20–30% of pregnant women, typically in the second and third trimesters, due to estrogen-mediated nasal mucosal engorgement. It resolves within 2 weeks of delivery.
- **First-line management:** Nasal saline irrigation and nasal strips. These are safe throughout pregnancy.
- **Intranasal corticosteroids:** Budesonide is the preferred agent (FDA former Category B; most pregnancy safety data available among INCs) [2].
- **Oral antihistamines:** Cetirizine and loratadine are generally considered acceptable in pregnancy when needed (former Category B). First-generation antihistamines (e.g., chlorpheniramine) have a longer safety track record but cause sedation.
- **Avoid:** Oral decongestants, especially pseudoephedrine in the first trimester (potential association with gastroschisis in some studies; the evidence is debated but caution is warranted). Phenylephrine should also generally be avoided.
- **Immunotherapy:** May be continued during pregnancy if already established but should not be initiated during pregnancy.
### Elderly
- **Senile rhinitis** (atrophic or dry rhinitis) is common in older adults, producing paradoxical thin, watery discharge due to impaired mucociliary function.
- **First-generation antihistamines** are on the **Beers Criteria** list of potentially inappropriate medications for older adults due to anticholinergic effects (confusion, urinary retention, sedation, falls). Second-generation agents are preferred.
- **Topical ipratropium** is often well tolerated and effective for watery rhinorrhea in elderly patients [3].
- **Oral decongestants** should be used with caution due to cardiovascular effects (hypertension, arrhythmia).
### Athletes
- Exercise-induced rhinorrhea is common, particularly in cold, dry air — triggered by the cooling and drying of nasal mucosa during mouth-breathing at high ventilation rates.
- **Intranasal ipratropium** before exercise may prevent exercise-induced rhinorrhea.
- **Oral decongestants (pseudoephedrine):** Listed as prohibited by the World Anti-Doping Agency (WADA) above certain urinary thresholds. Competitive athletes should check current WADA regulations before use.
- **Intranasal corticosteroids** are permitted by WADA and are an appropriate option for athletes with allergic rhinitis.
## When to Escalate
Use the following thresholds to decide the level of care needed:
### Self-Care Is Appropriate When:
- Symptoms are mild, bilateral, and consistent with a common cold (duration <10 days)
- No fever or only low-grade fever (<38.3 °C / 101 °F)
- Symptoms respond to OTC treatment and home measures
### See a Primary Care Provider (Same Day or Within a Few Days) When:
- Rhinorrhea persists **>10 days without improvement** — possible bacterial sinusitis
- Thick, purulent discharge accompanied by **facial pain and fever** lasting >3 days
- Recurrent episodes suggesting undiagnosed allergic rhinitis or structural issue
- Symptoms disrupt sleep, work, or quality of life despite OTC treatment
- Suspected medication-induced rhinitis or rhinitis medicamentosa
### Go to Urgent Care When:
- Moderate fever (38.3–39.4 °C) with worsening facial pressure and colored discharge ("double worsening" pattern)
- Significant unilateral **nosebleeds** that recur or are difficult to control
- Child with suspected nasal foreign body and stable vital signs
### Go to the Emergency Room / Call Emergency Services When:
- Clear, watery, unilateral discharge **after head injury** (suspected CSF leak)
- High fever (≥39.4 °C / 103 °F) with **periorbital swelling, severe headache, visual changes, or altered mental status** — possible orbital cellulitis or intracranial complication
- Signs of **anaphylaxis**: rapid-onset rhinorrhea with urticaria, throat tightness, wheezing, hypotension
- Immunocompromised patient with rapidly progressive nasal symptoms and **dark/necrotic tissue** visible on exam
## References
[1] Eccles R. Understanding the symptoms of the common cold and influenza. *Lancet Infect Dis*. 2005;5(11):718-725. PMID:16310147.
[2] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis. *Otolaryngol Head Neck Surg*. 2015;152(1 Suppl):S1-S43. PMID:25644617.
[3] Sur DK, Plesa ML. Chronic Nonallergic Rhinitis. *Am Fam Physician*. 2018;98(3):171-176. PMID:30215910.
[4] Deckx L, De Sutter AI, Guo L, Mir NA, van Driel ML. Nasal decongestants in monotherapy for the common cold. *Cochrane Database Syst Rev*. 2016;10(10):CD009612. PMID:27748955.
[5] King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. *Cochrane Database Syst Rev*. 2015;2015(4):CD006821. PMID:25892369.
[6] Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines — 2016 revision. *J Allergy Clin Immunol*. 2017;140(4):950-958. PMID:28602936.
[7] Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. *J Allergy Clin Immunol*. 2008;122(2 Suppl):S1-S84. PMID:18662584.
[8] De Sutter AI, Saraswat A, van Driel ML. Antihistamines for the common cold. *Cochrane Database Syst Rev*. 2015;2015(11):CD009345. PMID:26615034.
---
*This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of any medical condition.*
PillsCard
Loading PillsCard…
Loading the latest data0%